141 related articles for article (PubMed ID: 10569701)
1. The down-regulation of FcgammaRII and FcgammaRIIIB by N-formyl-methionyl-leucyl-phenylalanine (FMLP) depends on secretory events in human neutrophils.
Alves-Rosa MF; Vulcano M; Beigier M; Breyer I; Isturiz MA
Immunol Lett; 1999 Nov; 70(2):119-26. PubMed ID: 10569701
[TBL] [Abstract][Full Text] [Related]
2. The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo.
Beigier-Bompadre M; Barrionuevo P; Alves-Rosa F; Rubel CJ; Palermo MS; Isturiz MA
Scand J Immunol; 2003 Mar; 57(3):221-8. PubMed ID: 12641650
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D mediates Fc gamma receptor activation of neutrophils and provides specificity between high-valency immune complexes and fMLP signaling pathways.
Gewirtz AT; Simons ER
J Leukoc Biol; 1997 Apr; 61(4):522-8. PubMed ID: 9103240
[TBL] [Abstract][Full Text] [Related]
4. Aroclor 1242 stimulates the production of inositol phosphates in polymorphonuclear neutrophils.
Tithof PK; Contreras ML; Ganey PE
Toxicol Appl Pharmacol; 1995 Mar; 131(1):136-43. PubMed ID: 7878669
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
Fletcher MP
J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
[TBL] [Abstract][Full Text] [Related]
6. Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP).
Beigier-Bompadre M; Alemán M; Barrionuevo P; Franco MC; Rubel CJ; Sasiain Mdel C; Palermo MS; Abbate E; Isturiz MA
Clin Exp Immunol; 2003 Aug; 133(2):267-74. PubMed ID: 12869034
[TBL] [Abstract][Full Text] [Related]
7. [Effects of pepstatin A on neutrophils; cross-deactivation with FMLP].
Muniain MA; Pozuelo F; Pérez-Venegas JJ; Romero-Tabares A; Rodríguez-Hornillo MC; Garrido M
Rev Esp Fisiol; 1985 Mar; 41(1):125-31. PubMed ID: 2988085
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
9. N-formyl-methionyl-leucyl-phenylalanine inhibits both gamma interferon- and interleukin-10-induced expression of FcgammaRI on human monocytes.
Beigier-Bompadre M; Barrionuevo P; Alves-Rosa F; Rubel CJ; Palermo MS; Isturiz MA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):402-8. PubMed ID: 11238229
[TBL] [Abstract][Full Text] [Related]
10. Serum protects against azurophil granule dependent down-regulation of complement receptor type 1 (CR1) on human neutrophils.
Lundahl J; Dahlgren C; Gustavsson K; Hed J
Inflamm Res; 1995 Oct; 44(10):438-46. PubMed ID: 8564520
[TBL] [Abstract][Full Text] [Related]
11. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway.
Cassatella MA; Bazzoni F; Ceska M; Ferro I; Baggiolini M; Berton G
J Immunol; 1992 May; 148(10):3216-20. PubMed ID: 1578146
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
14. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559
[TBL] [Abstract][Full Text] [Related]
15. Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding.
Iannone MA; Wolberg G; Reynolds-Vaughn R; Zimmerman TP
Agents Actions; 1987 Aug; 21(3-4):278-80. PubMed ID: 2891263
[TBL] [Abstract][Full Text] [Related]
16. Cytochalasin B enhancement of the diacylglycerol response in formyl peptide-stimulated neutrophils.
Honeycutt PJ; Niedel JE
J Biol Chem; 1986 Dec; 261(34):15900-5. PubMed ID: 3782096
[TBL] [Abstract][Full Text] [Related]
17. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase inhibition attenuates stored blood-induced neutrophil activation: a novel adjunct to blood transfusion.
Lall RN; Loomis W; Melbostad H; Hoyt DB; Lane T; Coimbra R
J Am Coll Surg; 2006 Jan; 202(1):10-7. PubMed ID: 16377492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
